Targeting kinome reprogramming in ESR1 fusion-driven breast cancer

被引：0
|
作者：
Gou, Xuxu
Kim, Beom-Jun
Anurag, Meenakshi
Lei, Jonathan T.
Young, Meggie N.
Holt, Matthew V.
Fandino, Diana
Vollert, Craig T.
Singh, Purba
Alzubi, Mohammad A.
Malovannaya, Anna
Dobrolecki, Lacey E.
Lewis, Michael T.
Li, Shunqiang
Ellis, Matthew J.
Foulds, Charles E.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5011
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5011
引用
收藏
页数：3
相关论文
共 50 条
  • [11] On the evidence for ESR1 amplification in breast cancer
    Holst, Frederik
    Moelans, Cathy B.
    Filipits, Martin
    Singer, Christian F.
    Simon, Ronald
    van Diest, Paul J.
    NATURE REVIEWS CANCER, 2012, 12 (02) : 149 - 149
  • [12] The search for ESR1 mutations in breast cancer
    Steffi Oesterreich
    Nancy E Davidson
    Nature Genetics, 2013, 45 : 1415 - 1416
  • [13] The search for ESR1 mutations in breast cancer
    Oesterreich, Steffi
    Davidson, Nancy E.
    NATURE GENETICS, 2013, 45 (12) : 1415 - 1416
  • [14] Adaptive Reprogramming of the Breast Cancer Kinome
    Stuhlmiller, T. J.
    Earp, H. S.
    Johnson, G. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 (04) : 413 - 415
  • [15] The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer
    Vitale, Silvia R.
    Ruigrok-Ritstier, Kirsten
    Timmermans, A. Mieke
    Foekens, Renee
    Trapman-Jansen, Anita M. A. C.
    Beaufort, Corine M.
    Vigneri, Paolo
    Sleijfer, Stefan
    Martens, John W. M.
    Sieuwerts, Anieta M.
    Jansen, Maurice P. H. M.
    BMC CANCER, 2022, 22 (01)
  • [16] The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer
    Silvia R. Vitale
    Kirsten Ruigrok-Ritstier
    A. Mieke Timmermans
    Renée Foekens
    Anita M. A. C. Trapman-Jansen
    Corine M. Beaufort
    Paolo Vigneri
    Stefan Sleijfer
    John W. M. Martens
    Anieta M. Sieuwerts
    Maurice P. H. M. Jansen
    BMC Cancer, 22
  • [17] Targeting the Breast Cancer Kinome
    Miller, Samantha M.
    Goulet, Daniel R.
    Johnson, Gary L.
    JOURNAL OF CELLULAR PHYSIOLOGY, 2017, 232 (01) : 53 - 60
  • [18] ABERRANT METHYLATION OF ESR1 IN BLOOD AND ASSOCIATION WITH ESR1 NEGATIVE IN TUMOR OF BREAST CANCER PATIENTS
    Martinez-Galan, J.
    Torres-Torres, B.
    del Moral, R.
    Nunez, M. I.
    Valdivia, J.
    Luque, R.
    Penalver, J.
    Rios, S.
    De Almodovar, M. Ruiz
    Delgado, J. R.
    ANNALS OF ONCOLOGY, 2010, 21 : 52 - 52
  • [19] Molecular characterization of ESR1 variants in breast cancer
    Arielle L. Heeke
    Andrew Elliott
    Rebecca Feldman
    Hazel F. O’Connor
    Paula R. Pohlmann
    Filipa Lynce
    Sandra M. Swain
    Maria R. Nunes
    Daniel Magee
    Matthew J. Oberley
    Jeffrey Swenson
    Gregory Vidal
    Claudine Isaacs
    Lee Schwartzberg
    W. Michael Korn
    Antoinette R. Tan
    Breast Cancer Research and Treatment, 2022, 196 : 279 - 289
  • [20] Molecular characterization of ESR1 variants in breast cancer
    Heeke, Arielle L.
    Elliott, Andrew
    Feldman, Rebecca
    O'Connor, Hazel F.
    Pohlmann, Paula R.
    Lynce, Filipa
    Swain, Sandra M.
    Nunes, Maria R.
    Magee, Daniel
    Oberley, Matthew J.
    Swenson, Jeffrey
    Vidal, Gregory
    Isaacs, Claudine
    Schwartzberg, Lee
    Korn, W. Michael
    Tan, Antoinette R.
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 196 (02) : 279 - 289
12345